Latest news News from The International Liver CongressVisit our conference news pages. Lucy Garvey and Daniel Fierer at CROI 2019. Photo by Liz Highleyman.News from CROI 2019Hepatitis C drops among HIV-positive London gay men after direct-acting antiviral scale-up. Hepatitis news bulletinSign up for our monthly hepatitis news bulletin. infohep news Antiviral therapy Tenofovir may lower the risk of liver cancer more than entecavir Liz Highleyman / 18 April 2019 People with hepatitis B who were treated with tenofovir disiproxil fumarate (TDF; Viread) were less likely to develop hepatocellular carcinoma (HCC) than those treated with entecavir (Baraclude) in a large observational study, according ... Antiviral therapy Core protein inhibitor shows promising activity against hepatitis B Liz Highleyman / 16 April 2019 An experimental hepatitis B virus (HBV) core protein inhibitor led to greater reductions in HBV viral load and residual HBV genetic material when added to nucleoside/nucleotide analogues, which could lead to a functional ... View all infohep news Editors' picks from other sources Previous HAV vaccination does not reliably protect some patients with HIV Healio / 18 April 2019 England hits WHO 2020 hepatitis C target three years early The Pharmaceutical Journal / 18 April 2019 Hepatic Steatosis Highly Prevalent in Young Adults With Lifelong HIV Infectious Disease Advisor / 17 April 2019 View all news from other sources Conference news More conference news Noticeboard ILC 2016 webinar: watch again More noticeboard posts Email updates Sign up for our monthly bulletins Sign up today Other pages in this section Latest news All the news Conference news Noticeboard Email bulletins News feeds